BUFFALO, NY / ACCESSWIRE / September 27, 2024 / POP Biotechnologies (POP BIO), a Buffalo, NY-based biopharmaceutical company, ...

Syndicate has today announced the first cohort of awardees of its Collaborative Discovery Programme (CDP) funding.The £3 ...

PACE (Pathways to Antimicrobial Clinical Efficacy) has today launched its second funding round with up to £5 million ...

SmartHMS, a leading healthcare management solutions provider based in India, is proud to announce the ongoing success and ...

The global diabetic gastroparesis treatment market is poised for significant growth, driven by the increasing prevalence of ...

HOUSTON, TX / ACCESSWIRE / September 27, 2024 / MasterWord is honored to announce its partnership with UNESCO, within its ...

Humaneva CEO - Tomasz D?browski WARSAW, Poland, September 27, 2024 (Newswire.com) - Humaneva Inc. has entered into a ...

Epitopea, a transatlantic cancer immunotherapy company, and CQDM are proud to announce the launch of a collaborative research project between Epitopea and Université de Montréal (UdeM), a leading ...

LEO Pharma A/S, a global leader in medical dermatology, today announced positive results from the Phase 2a Mechanism of Action (MoA) trial, which assessed the mechanistic impact of investigational ...

Bayer AG and Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, today announced a new strategic collaboration with ...

Dupixent is indicated for the approximately 300,000 adults in the US with inadequately controlled COPD and an eosinophilic phenotypeFollowing recent approvals in the EU and China, the US approval is ...

Today is European Myeloma Day, a date dedicated to raising awareness of key issues affecting myeloma patients across Europe. This year, Myeloma Patients Europe (MPE) is highlighting the role of ...